SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk ($SNDK) is trending due to its inclusion in the S&P 500, replacing Interpublic Group ($IPG), sparking bullish sentiment. The community is discussing whether the recent surge is justified, with some anticipating a pullback while others foresee continued upward momentum towards $300. Analysts' price target increases and reported undersupply in the NAND market are also fueling the conversation.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as investors digest the implications of its oral semaglutide failing to meet endpoints in Alzheimer's trials, leading to a significant stock drop. The community is debating whether this sell-off is an overreaction, considering the company's continued dominance in the weight loss market and the potential approval of its oral Wegovy. Some investors view the dip as a buying opportunity, while others express concern about the company's future prospects amidst increasing competition.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America and Australia (NAA) Cruise, Europe and Asia (EA) Cruise Operations, Cruise Support, and Tour and Others. The North America and Australia (NAA) Cruise segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe and Asia (EA) Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corp. - Ordinary Shares (Paired Stock)

Carnival Corp

Cruise line stocks, including CCL, experienced a sudden drop, leaving traders searching for a clear catalyst. Community discussions highlight concerns about cautious outlooks on the U.S. macroeconomic environment and potential headwinds from Caribbean capacity growth. Some traders are pointing to possible manipulation, while others are looking for a buying opportunity amid the uncertainty.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending as the community discusses the company's future prospects following the commercial launch of Tonmya, with some questioning its potential impact amidst concerns of dilution.  Bulls express optimism about the new drug and potential for a short squeeze, while bears cite concerns about the company's history and financial management. Discussions also include institutional ownership, possible buyback, and potential buyout.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Zoom Video Communications, Inc.

Zoom ($ZM) is trending as the community discusses its potential for AI-driven growth following recent earnings and analyst ratings updates, despite concerns about market competition and historical performance. Community talking points revolve around its cash reserves, innovation, and potential acquisitions. Broader discussions involve whether Zoom can move beyond its pandemic-era association and solidify its position in the UCaaS landscape.

Symbotic, Inc. is an automation technology company, which engages in a robotics and automation-based product movement technology platform. It focuses on developing, commercializing, and deploying innovative, end-to-end technology solutions for supply chain operations. It operates through the United States and Canada geographical segments. The company was founded by Richard B. Cohen on December 11, 2020 and is headquartered in Wilmington, MA.

Symbotic Inc - Ordinary Shares - Class A

Symbotic Inc 

Symbotic is trending following its Q4 earnings release, with community members weighing the positive revenue growth against concerns about valuation and customer concentration. Discussions also include the company's long-term potential in warehouse automation and the impact of recent shifts in risk factors, including retail dependency and supply chain vulnerabilities. Bullish sentiment remains, with some anticipating a continued rise and potential short squeeze.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as investors discuss potential data integrity concerns from a recent trial and its implications for future FDA meetings. Community members are debating the validity and impact of the data, with some suggesting a possible buyout or partnership on the horizon. The stock's movement is also influenced by competitor activity and discussions around potential acquisition targets.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

GALT is trending as traders discuss trading halts on some platforms, potential manipulation, and the possible implications for shorts; the community speculates this could be related to upcoming news or a potential short squeeze. Chatter about brokerages restricting buying has fueled speculation, while others point to the strong science and data presented as a positive catalyst. Discussions about a potential buyout continue, with many closely watching for FDA feedback.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy ($FLNC) is trending following Q4 earnings and fiscal year 2026 guidance, with the community highlighting record order intake and backlog growth, signaling strong expansion in the BESS (Battery Energy Storage Systems) market. Bullish sentiment is fueled by the company's outlook, with many believing revenue guidance will be surpassed. Discussions also involve potential benefits from domestic content strategies and increased demand driven by AI and data centers.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending due to positive sentiment around its role in AI infrastructure, particularly following Google's Gemini 3 model announcement and news of potential Saudi investment in AI chips. Community members are weighing AVGO's AI prospects against those of competitors like NVDA, with some highlighting Broadcom's custom chip advantage and attractive dividend yield, while others point to a potential overvaluation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy Virax Biolabs Believes Technology Aligns with United...

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Virax Biolabs' CEO James Foster Issues Letter to Shareholders Virax Biolabs' CEO James Foster Issues Letter to Shareholders PR Newswire LONDON, Dec. 17, 2024 LONDON, Dec. 17, 2024 /PRNewswire...

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland Virax Biolabs Announces Agreement with Tebubio to Expand...

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland Virax Biolabs Announces Distribution Agreement with Europa Biosite...

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc. Virax Biolabs Announces...

Virax Biolabs to Participate at 7th European Congress of Immunology

Virax Biolabs to Participate at 7th European Congress of Immunology Virax Biolabs to Participate at 7th European Congress of Immunology PR Newswire LONDON, Aug. 29, 2024 LONDON, Aug. 29, 2024...

What's Going On With Virax Biolabs Stock Wednesday

Virax Biolabs stock is trading higher on Wednesday after the company announced it entered into a distribution agreement with a supplier of RT-PCR Mpox detection kits.
read more...

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East Virax Biolabs Announces Distribution Agreement to...

EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East

Virax Biolabs has signed a distribution agreement to commercialize RT PCR Mpox virus detection kits in Europe and Gulf countries, amid a WHO-declared international health emergency due to rising mpox...

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of...

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

Virax Biolabs Group Ltd - Ordinary Shares - Class A

Buying

Holding

Selling or trimming

Watching from the sidelines

What are you doing with Alphabet ($GOOGL) stock as it hits fresh all-time highs?

VRAX
Virax Biolabs Group Ltd

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest VRAX News

VRAXVirax Biolabs Group Ltd